| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | INTREXON CORP | 62,147,301 | 1,873,741,000 | 74.88% | ||
| 2 | HALOZYME THERAPEUTICS INC | 19,829,337 | 343,642,000 | 13.73% | ||
| 3 | ZIOPHARM Oncology, Inc. | 9,692,403 | 80,544,000 | 3.22% | ||
| 4 | FIBROCELL SCIENCE | 16,620,414 | 75,623,000 | 3.02% | ||
| 5 | SYNTHETIC BIOLOGICS INC | 13,238,268 | 30,315,000 | 1.21% | ||
| 6 | ENTERPRISE PRODS PARTNERS L | 1,035,834 | 26,497,000 | 1.06% | ||
| 7 | ORAGENICS INC | 13,220,225 | 19,831,000 | 0.79% | ||
| 8 | ENERGY TRANSFER EQUITY L P COM UT LTD PTN | 752,400 | 10,338,000 | 0.41% | ||
| 9 | Histogenics Corporation | 2,690,570 | 9,417,000 | 0.38% | ||
| 10 | GENESIS ENERGY L P | 217,000 | 7,973,000 | 0.32% | ||
| 11 | TC PIPELINES LP | 97,000 | 4,822,000 | 0.19% | ||
| 12 | NUSTAR ENERGY LP | 116,500 | 4,672,000 | 0.19% | ||
| 13 | AMPLIPHI BIOSCIENCES CORP | 1,158,788 | 4,612,000 | 0.18% | ||
| 14 | OVASCIENCE INC COM | 373,224 | 3,646,000 | 0.15% | ||
| 15 | Martin Midstream Partners LP | 141,800 | 3,077,000 | 0.12% | ||
| 16 | ENERGY TRANSFER PRTNRS L P | 85,135 | 2,872,000 | 0.11% | ||
| 17 | Transgenomic Inc | 770,490 | 824,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-049489, filed 2016.02.01).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
